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Abstract
Pelvic bottom dysfunction includes sexual dysfunction, lower urinary tract dys-
function, defecation dysfunction, etc., and the quality of daily life is significantly 
impaired. Although drug based and surgical therapies exist as treatment methods, 
non-invasive treatment methods for pelvic floor dysfunction are highly desired, and 
magnetic stimulation therapy is attracting attention as a potential new approach. 
Magnetic stimulation therapy can generate deeper stimulations as compared to 
electrical stimulation therapy, is less painful, and can be performed while wearing 
clothes. In addition, it is a very safe treatment method with only few reports of side 
effects. From nocturnal enuresis in children to middle-aged sexual dysfunction 
and urinary incontinence in the elderly, therapeutic effects on various pelvic floor 
dysfunctions have been confirmed regardless of age and gender. It is expected that 
magnetic therapy will continue to develop as a new therapy in the futures. This 
chapter first describes the pelvic floor muscles and the principles of anatomy and 
magnetic therapy. In addition, the therapeutic effects of magnetic therapy will be 
explained in detail one by one. We will also explain the potential application of 
magnetic therapy for sarcopenia, which is a problem in our aging society.
Keywords: magnetic stimulation therapy, pelvic floor muscles, urinary incontinence, 
men’s health, sarcopenia
1. Introduction
The pelvis contains organs such as the bladder, prostate, (uterus in women), and 
rectum, and the pelvic floor muscles are the underlying muscles. The pelvic floor 
muscles wrap around the pelvic bones and support several organs. Some pelvic 
floor muscles form a sling around the rectum for greater stability. The function-
ing of these pelvic floor muscles maintains urination, defecation, and sexual life. 
However, if the muscles at the bottom of the pelvis cannot be properly relaxed 
during urination or defecation, urinary incontinence, fecal incontinence, ED, and 
women will experience pain during sexual intercourse.
Pelvic bottom dysfunction (PFD) is a disease caused by damage, dysfunc-
tion, and degeneration of pelvic bottom supporting tissue, which is advocated by 
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the International Urological Society (IUGA) and the International Continence 
Society (ICS). It mainly includes pelvic organ prolapse (POP), pelvic pain, sexual 
dysfunction, lower urinary tract (LUT) abnormality, and defecation dysfunction. 
The causes of such pelvic floor muscle dysfunction are not known at all, but aging, 
obesity, pregnancy, pelvic surgery, etc. are known as factors.
The first non-invasive treatment proposed for pelvic floor muscle dysfunction 
is pelvic floor muscle training (PFMT), but the results are inconsistent. Systematic 
review and meta-analysis of non-surgical treatments for urinary incontinence, 
examining combinations of five common interventions: PFMT, electrical stimula-
tion (ES), vaginal cone (VC), bladder training (BT), and serotonin-noradrenaline 
reuptake inhibitors (SNRIs). This study reported that more intense PFMT was an 
effective treatment, but incontinence assessment methods and intervention proto-
cols differed between studies, and further research is needed [1]. Given the diffi-
culty and effectiveness of sustaining PFMT, new conservative therapies are needed 
to replace pelvic floor muscle training.
In recent years, the US Food and Drug Administration has approved magnetic 
stimulation as a new non-invasive treatment method for pelvic floor muscle dysfunc-
tion. Magnetic stimulation therapy is a method of non-invasively stimulating central 
nerves and peripheral nerves using electric current generated by magnetism. This 
method was previously used in the fields of neurology and orthopedics as transcra-
nial magnetic stimulation and skeletal muscle magnetic stimulation, but in the field 
of urology, it is mainly used for the treatment of urinary incontinence. Furthermore, 
magnetic stimulation therapy has been found to be effective not only in urinary 
incontinence but also in a series of diseases related to the pelvic floor muscles.
This paper focuses on magnetic stimulation therapy and introduces various 
therapeutic effects on pelvic floor muscle disorders.
2. Functional anatomy of the pelvic floor muscles
The bottom of the pelvis has a three-layer structure from the upper part to the 
visceral pelvic diaphragm, the pelvic diaphragm, and the urogenital diaphragm. The 
target approach to the pelvic floor muscles is the muscles in the second layer of the pel-
vic diaphragm. The pelvic diaphragm mainly consists of the levator ani and coccygeus 
muscles. The levator ani muscle consists of medial and lateral muscles, and the medial 
pubococcygeus is inside the levator ani tendon arch, originating from the pelvic fascial 
tendon arch, supporting the outside of the vagina and rectum, and attaches to the 
anterior sacrococcygeal ligament. The lateral iliococccygeus muscle begins at the leva-
tor ani tendon arch and attaches to the tip and lateral edge of the coccyx. The levator 
ani and coccygeus muscles form the pelvic diaphragm and close the pelvic outlet. The 
left and right levator ani muscles do not intersect in the center and form a fissure that 
penetrates the urethra, vagina, and rectum. On the other hand, the coccygeus muscle 
covers the inner surface of the ischial spine to the inner surface of the sacral ligament 
and attaches to the lower part of the sacrum and the outer edge of the coccyx.
3. Motor function of the pelvic floor muscles
The pelvic floor muscles support the organs and are active at rest. Therefore, 
the pelvic floor muscle group is composed of slow muscle fibers that act as posture 
maintenance at a high rate. Furthermore, the pelvic floor muscles do not work 
alone, and when the pelvic floor muscles are contracted, the abdominal muscles 
contract, and conversely, when the abdominal muscles are contracted, the pelvic 
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floor muscles are also activated. When the abdominal pressure rises, the pelvic floor 
muscles and abdominal muscles move inward. However, in cases of dysfunction of 
the pelvic floor muscle group such as urinary incontinence, the pelvic floor muscle 
group and the abdominal muscle move outward [2].
4. What is magnetic stimulation therapy?
4.1 Principle of magnetic stimulation therapy
When an electric current is passed through the coil, a magnetic field is generated 
along the coil axis. An electric field is induced in proportion to the rate of change of 
the magnetic field, stimulating skeletal muscle, the autonomic nervous system, and 
the somatic nervous system. When a pulsed current is passed through the coil of a 
chair, a pulsed magnetic field is generated in the pelvis and an eddy current is gener-
ated. The eddy current stimulates the pelvic floor muscles, which are mainly the pel-
vic nerve, and suppresses the pelvic nerve and stimulates the lower abdominal nerve 
via the afferent fibers of the pelvic nerve and bladder, and the urinary muscle. As a 
result, the pressure in the urethra increases and bladder contraction is suppressed.
4.2 Advantages and disadvantages of magnetic stimulation therapy
There are three major advantages of magnetic stimulation therapy compared to 
electrical stimulation therapy. One is the depth of stimulation. Magnetic stimulation 
therapy can stimulate nerves deeper than electrical stimulation. Currently, in Japan, 
a chair-type stimulator that magnetically stimulates the area around the anus is used. 
Such stimulation of deep nerves is difficult to reproduce with electrical stimulation 
therapy.
The second is that it can be done non-invasively. Since the magnetic stimulation 
penetrates clothes, skin, bones, etc., it can be performed while wearing clothes 
without inserting an anus or vaginal electrodes. Therefore, this treatment method is 
more comfortable and less embarrassing. Furthermore, the targets to be stimulated 
are the sacral nerve and the pelvic floor, but treatment can be performed without 
pain often observed in electrical stimulation.
The third is safety. Magnetic stimulation therapy is considered to be an extremely 
safe and side-effect-free treatment. In a multicenter, randomized, sham-controlled 
trial, magnetic stimulation therapy did not show any adverse events compared to the 
placebo group [3]. This data suggests that magnetic stimulation is safer than electrical 
stimulation associated with side effects such as abdominal pain and diarrhea [4].
However, there are two major disadvantages. One is the need to go to the hospi-
tal. Magnetic therapy does not end with just one treatment, and requires about 8–16 
visits in 1 to 2 months. Depending on access to the hospital and the patient’s health 
condition, this might be challenging. The second disadvantage is that this can be a 
difficult intervention in certain patients. For example, in patients with a pacemaker, 
Pros Cons
• stimulation of nerves in deep muscles
• no requirement for dressing change
• minimal side effects
• difficult to perform on patients who is with tattoo or a 
pacemaker.
Table 1. 
Pros and cons of magnetic stimulation therapy.
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magnetic therapy can cause malfunctions, and in patients with tattoos, the likeli-
hood of burns increases (Table 1).
5. Therapeutic effect of magnetic therapy
5.1 Effect on urinary incontinence
Urinary incontinence (UI) is a common urinary disease and is usually defined as 
involuntary urine leakage due to weakening of the urethral sphincter and pelvic floor 
muscles without the need for urination [5]. According to the International Continence 
Association (ICS), urinary incontinence affects more than 200 million people 
worldwide, primarily women. Half of women may not report UI, perhaps because of 
embarrassment, lack of knowledge about treatments, and the belief that UI is normal 
with age. Urinary incontinence can be divided into (i) stress incontinence (ii) urge 
incontinence (iii) mixed incontinence, which is a combination of the two types. Stress 
urinary incontinence accounts for 29–75% of women, urge incontinence accounts for 
7–33% of the population, and mixed urinary incontinence accounts for 14–61% of the 
population. Men may also develop urinary incontinence due to urethral sphincter defi-
ciency after radical prostatectomy, adversely affecting the patient’s quality of life [6]. 
Controlling urinary incontinence is also an important issue for extending healthy life 
expectancy. It is known that the prevalence of urinary incontinence increases with age 
in the elderly. A large database analysis in Northern California found that the risk of 
admission to a long-term care facility after diagnosis of urinary incontinence was twice 
as high for women and 3.2 times for men, and increased the risk of hospitalization [7].
Various research reports have been published on the therapeutic effect of magnetic 
stimulation on stress urinary incontinence (SUI). In a randomized, double-blind, sham 
controlled trial of 120 female patients with SUI, the treatment group received magnetic 
stimulation twice a week for a total of 16 times over a two-month period. When the 
primary endpoint is a decrease in the score of ICIQ-UI SF (International Consultation 
on Incontinence Questionnaire for Urinary Incontinence-Short Form) by 5 points as the 
therapeutic response, the therapeutic response in the magnetic therapy group is 3.46 
times that in the placebo group. The total score of ICIQ-UI SF decreased significantly. 
There was also a consistent significant improvement in score between 1 and 2 months, 
indicating that 8-week PMS was more effective than 4-week. An additional year of 
follow-up suggested that the effect was long-lasting [8]. In a pilot study comparing 52 
randomized patients with SUI, the treatment group showed lower myostatin levels and 
improved UI severity ratings (The Revised Urinary Incontinence Scale) and depression 
severity (Beck Depression Inventory) before and after treatment [9]. In a randomized, 
sham-controlled trial of 30 female SUI patients resistant to pelvic floor muscle training, 
magnetic stimulation significantly improved ICIQ-SF and the abdominal leak point 
pressure (ALPP) in the treatment group compared to baseline, with significant differ-
ences between groups (P < 0.05). In addition, self-efficacy beliefs (GSES) improved 
in the magnetic therapy group, and the authors reported that there were effects of 
magnetic therapy on both physical and psychosocial aspects [10]. In a randomized 
controlled trial of three groups of women with SUI: a pelvic floor muscle training and 
extracorporeal magnetic therapy group and a control group, the two treatment groups 
showed a decrease in depressive symptoms (BDI-II) and significant improvements in 
an improvement in urinary incontinence severity (RUIS) and several quality of life 
items (KHQ). Moreover, GSES improved in the extracorporeal magnetic therapy group 
[11]. A study was also conducted to evaluate the effect of sacral magnetic stimulation 
(SMS) on functional and urodynamic improvement in patients 45–75 years of age with 
refractory SUI. This study was a sham-controlled, double-blind, parallel study with a 
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follow-up of 4.5 months [12]. Compared to the sham group, the experimental group 
showed significant improvement in Urge-Urinary Distress Inventory and Overactive 
Bladder Questionnaire (OAB-q) scores after the intervention and also at follow-up. 
In addition, there were significant increases in bladder capacity, urethral functional 
length, and pressure transmission ratio after the intervention. The response to SMS was 
greater in patients with severe SUI than in patients with mild symptoms, confirming the 
effectiveness of SMS in the treatment of SUI. In another study, a total of 75 patients with 
stress urinary incontinence were subjected to repetitive magnetic stimulation of 15 Hz. 
at the sacral root at 50% intensity output for 30 minutes with a duration of 5 seconds 
per minute. As a result, an obvious increase in urethral closing pressure and a significant 
increase in bladder capacity after stimulation were observed in the sacral stimulation 
group. In addition, the number of urine leaks and urine volume in the pad test were 
significantly decreased in the active stimulation group than in the sham stimulation 
group, and the QOL score was also significantly improved. The improvement rate of the 
active stimulation group was 74%, which was significantly higher than that of the sham 
stimulation group (32%) [13]. A randomized controlled trial investigating the short- 
and long-term effects of repetitive magnetic stimulation on the sacral root observed an 
improvement in the quality of life of patients with abdominal stress urinary inconti-
nence at one week after stimulation [14].
Some studies have reported therapeutic effects on urge and mixed urinary inconti-
nence. In a multicenter, randomized, single-blind, controlled trial of 151 women with 
urge incontinence with overactive bladder, armchair-type magnetic stimulators were 
used to stimulate magnetically twice a week for 25 minutes. As a result, the number 
of urine leaks / week according to the bladder diary was significantly improved in the 
treatment group, and the urgency within 24 hours and the average excretion amount 
were also significantly improved. In addition, the change in total OABSS from baseline 
was significantly lower in the treatment group than in the sham group, and the change 
in mean IPSS-QOL score was also significantly lower in the treatment group [3]. A 
retrospective study conducted in Italy examined the effects of magnetic therapy on 20 
men and women with stress incontinence, urge incontinence, and mixed incontinence. 
The treatment was performed using a functional magnetic stimulator and a magnetic 
coil installed under the seating surface of the chair. During treatment, the patient 
was instructed to sit in a chair so that the perineum was centered on the coil and that 
muscle contractions (pelvic floor and sphincter contractions) were felt during stimula-
tion. Patients were treated for 20 minutes / session, twice a week for 3 weeks (6 times 
in total). The stimulation frequency was fixed at 10 Hz for 10 minutes and at 35 Hz 
for another 10 minutes, and the activity time and rest time were 6 seconds each. As a 
result, micturition frequency and nocturia were significantly reduced before and after 
treatment, and bladder capacity was significantly increased [15]. A study of 82 female 
patients with various urinary incontinences in Slovenia received 10 magnetic stimuli 
over a 4-week period. As a result, in urge incontinence and mixed incontinence, the 
frequency of urinary incontinence, the number of daily urinary incontinence, and the 
decrease in the number of urination were statistically observed [16].
5.1.1 Postoperative urinary incontinence of prostate cancer
Prostate cancer is the number one cancer in Europe and the United States that 
affects men. Surgery and radiation therapy are used for localized prostate cancer. 
Although surgical invasion has been significantly reduced due to the spread of surgi-
cal robot Da Vinci technique in recent years, postoperative stress urinary incontinence 
caused by removal of the prostate reduces the patient’s QOL. In a multicenter study 
in the United States, 46% of patients required a urinary incontinence pad 6 months 
after surgery, and urinary incontinence often persists long after surgery [17]. In a 
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previous study, 10 patients who had been suffering from urinary incontinence for 
more than 12 months after radical prostatectomy were treated with magnetic therapy 
for 20 minutes, twice a week for 2 months. The pulsed field frequency was 10 Hz for 
10 minutes, followed by a second treatment at 50 Hz for 10 minutes. As objective and 
subjective evaluations, a micturition diary, a 1-hour pad weight test, and a quality 
of life survey were performed 1, 2, 3, and 6 months after the start of treatment. As 
a result, 30% of patients became dry and 30% showed improvement. In the 1-hour 
pad weight test, the average pad weight decreased from 25 to 10.3 g, and the QOL 
score improved significantly 2 months after treatment. In addition, the number of 
urine leaks per day decreased from 5.0 before treatment to 1.9 after treatment [18]. 
Although robotic surgery has improved the degree of urinary incontinence, 14% of 
patients in our department still use two or more urinary incontinence pads/day after 
6 months post surgery. In order to improve this annoying complication after surgery, 
our facility is currently actively adopting magnetic therapy.
5.2 Effect on detrusor overactivity
Detrusor overactivity is a common cause of urge incontinence in elderly and 
young patients. It occurs when the detrusor muscle contracts intermittently for no 
apparent reason when the bladder is partially or almost completely filled. Detrusor 
overactivity can be idiopathic or due to dysfunction of the detrusor center of the 
frontal lobe (generally due to age-related changes, dementia, or stroke) or lower 
urinary tract obstruction. Urinary muscle overactivity with contractile force disor-
der is a variant of urgency urinary incontinence, characterized by urinary urgency, 
pollakiuria, decreased urinary retention, urinary retention, bladder pillar forma-
tion, and post-micturition residual urine volume of over 50 mL. In a study compar-
ing magnetic therapy with the placebo group for idiopathic detrusor hyperactivity, 
the magnetic therapy group significantly reduced the number of micturitions per 
day compared to the placebo group. It was also confirmed that the number of urina-
tion and QOL per day improved although the sample size was not sufficient [19].
In a randomized controlled trial of 32 men and women comparing the effects of 
magnetic and electrical stimulation, a significant increase in bladder capacity was 
found in the magnetic stimulation group [20].
5.3 Effect on neurogenic overactive bladder
Neurogenic bladder is a lower urinary tract dysfunction caused by a neurological 
disorder, and the diagnosis is based on urodynamic testing. When the upper part of 
the pontine detrusor center existing in the brain stem is damaged, neurogenic detru-
sor overactivity causes the bladder to contract involuntarily against the intention of 
the person occurs, resulting in urge incontinence and pollakiuria. In a study compar-
ing the effects of pulsed electromagnetic field therapy (PEMFT) and transcutaneous 
electrical nerve stimulation (TENS) on neuropathic overactive bladder dysfunction 
in patients with spinal cord injury (SCI), 50 male and 30 female patients (average 
age of 40 years) with secondary neuropathic overactive bladder due to spinal cord 
injury were recruited. Urinary tract dynamics (UDS) were performed before and 
after treatment. 40 patients received TENS (10 Hz, 700 second pulse) 3 times/week, 
for a total of 20 times and the remaining 40 patients received PEMFT (15 Hz, 50% 
intensity 5) 3 times/week, for a total of 20 times. As a result, the maximum cysto-
metric capacity, volume at first uninhibited detrusor contraction, and maximum 
urinary flow rate were significantly increased in the PEMFT group, indicating that 
PEMFT is superior to TENS in terms of therapeutic effect [21].
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5.4 Effect on bedwetting
Nocturnal enuresis is usually the involuntary urination during sleep after the age 
at which bladder control begins. According to the American Psychiatric Association’s 
DSM-IV, primary nocturnal enuresis (PNE) was described as “children 5 years and 
older who repeatedly urinate in bed and clothing twice a week for at least 3 con-
secutive months, not resulting from side effects and medical conditions of drugs. “ 
Nocturnal urine in children and adults causes mental stress and sometimes causes 
complications such as urinary tract infections. A study evaluating the potential clini-
cal and urodynamic effects of functional magnetic stimulation (FMS) in the treat-
ment of girls with primary nocturnal enuresis (PNE) compared to placebo reported 
the effects of magnetic therapy. 20 PNE girls (average age of 10.8 years) were given a 
magnetic stimulator for 2 months day and night, the number of episodes of noctur-
nal urine decreased from 3.1 to 1.3 times a week in the magnetic therapy group before 
and after treatment. In addition, the bladder volume at the strong desire to void 
increased significantly compared with the placebo group [22].
Monosymptomatic nocturnal enuresis (MNE) refers to patients with nocturnal 
enuresis without other lower urinary tract symptoms such as daytime urinary inconti-
nence and urgency. In a study that randomly assigned 44 patients with MNE to receive 
10 sets of repetitive sacral root magnetic stimulation (rSMS), the treatment group 
significantly improved the mean nocturnal urine per week compared to the placebo 
group. The effect was maintained even 1 month after the treatment. The treatment 
group also showed improvement in visual analog scale (VAS) and quality of life [23].
5.5 Effect on chronic pelvic pain syndrome
Chronic pelvic pain syndrome includes inflammation of the prostate gland, pain 
from the lower abdomen to the lower body, discomfort around the pelvic body, uri-
nary symptoms such as close urine and feeling of residual urine, discomfort during 
ejaculation, and erectile dysfunction. It is a disease reminding of sexual dysfunc-
tion. Although the exact causes have not been clarified yet, blood flow disorders 
and autoimmune reactions around the prostate gland, urine reflux into the prostate 
gland due to dysuria, sensory nerve abnormalities in the pelvis and lower body, 
adrenal gland hormones and abnormalities in sex hormones are believed to be the 
causes. It is often seen in relatively young people (late teens to 40s), and the symp-
toms worsen when the perineal area is compressed by a long sitting posture (desk 
work, driving a car, bicycle, motorcycle, etc.).
In addition, psychological stress, fatigue, smoking, excessive drinking, and 
poor circulation are also factors that worsen the symptoms. It is characterized by 
the absence of typical symptoms but various symptoms from the lower abdomen 
to the lower body start to appear. Pain may be felt not only in the perineum near 
the prostate, but also in areas not related to the prostate, such as the lower back, 
urethra, groin, thighs, and lower abdomen. In addition, it may be accompanied by 
urinary symptoms such as close urine, feeling of residual urine, weak urine momen-
tum, pain in the urethra when urinating, and sexual dysfunction such as discomfort 
during ejaculation and erectile disorder.
A randomized, placebo-controlled, double-blind study of 60 men with refrac-
tory chronic pelvic pain syndrome evaluated improvement in the Chronic Prostatic 
Inflammatory Symptom Index (NIH-CPSI) of the National Institutes of Health. The 
QOL score was significantly improved 12 weeks after treatment compared to the 
placebo group. In addition, patients with persistent symptoms of 1 year or less were 
more effective than patients with long-lasting symptoms [24].
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On the other hand, there are also studies in which randomized, double-blind, 
placebo-controlled treatment was used for chronic pelvic pain in women. In this 
study, 32 patients with chronic pelvic pain were treated with active magnets (500G) 
or placebo magnets 24 hours a day at trigger points in the abdomen. After 1 month 
of treatment, McGill Pain Questionnaire, Pain Disability Index and Clinical Global 
Impressions Scale were evaluated. As a result, the Pain Disability Index, Clinical 
Global Impressions-Severity, and Clinical Global Impressions-Improvement were 
significantly lower in the treatment group than in the placebo group, demonstrating 
the therapeutic effect of magnetic therapy [25].
5.6 Effect on fecal incontinence
Fecal incontinence is defined as an involuntary leak of liquid or solid stool that 
poses a social or hygienic problem. Fecal incontinence is not life-threatening, but 
it is an intolerable symptom for patients and significantly impairs their quality of 
life. The prevalence of fecal incontinence over the age of 65 in Japan is 8.7% for men 
and 6.6% for women. In the elderly, the onset of fecal incontinence often triggers 
admission to a facility, and it is thought that even for home care recipients, the most 
worrying thing about caregivers is receiving excretory care. Fecal incontinence is 
classified into leaky fecal incontinence, in which stool leaks without being noticed, 
urgent fecal incontinence, in which stool leaks without being able to endure the 
toilet, and mixed fecal incontinence, which is a mixture of both. It is roughly 
divided into. Leaky fecal incontinence is more likely to occur when the internal anal 
sphincter is impaired, and urgent fecal incontinence is more likely to occur when 
the external anal sphincter is impaired. The internal anal sphincter muscles often 
weaken with age, and the external anal sphincter muscles are often injured by labor 
or surgery for rectal cancer.
Surgical treatments for fecal incontinence include sacral stimulation therapy, 
anal sphincter plasty, and stoma construction. From the viewpoint of evidence and 
invasiveness, it is desirable to try non-invasive therapies first. Non-invasive thera-
pies include diet / lifestyle / defecation habit guidance, drug therapy, pelvic floor 
muscle training, biofeedback therapy, butt plugs, and retrograde intestinal lavage 
(irrigation defecation). The objectives are fecal solidification, increased contractil-
ity of the pelvic floor muscles, including the external anal sphincter, normalization 
of rectal sensation, and regular emptiness of the rectum and colon.
In a study reporting the effects of magnetic therapy on fecal incontinence, 10 
patients with fecal incontinence with an average age of 57 years received perineal 
magnetic stimulation (10 Hz and 50 Hz) twice weekly for 5 weeks. Both 10 Hz 
and 50 Hz stimulation significantly increased anal pressure compared to baseline 
rest. After treatment, anal pressure increased significantly and the score for fecal 
incontinence improved significantly [26].
6. Application to men’s health
Erectile dysfunction (ED), one of the male sexual dysfunctions, is defined as 
persistent or recurrent erections that are insufficient or unsustainable for satisfac-
tory sexual activity. ED is the second most common sexual problem in men after 
premature ejaculation, and epidemiological studies indicate that it affects 30 mil-
lion people in the United States. ED has a strong negative impact on self-esteem and 
self-confidence, can reduce the quality of life for men and their partners, and can 
affect all aspects of life. The pathophysiology of ED includes angiogenic, neuro-
genic, anatomical, hormonal, drug-induced, and / or psychogenic causes.
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Risk factors for ED include aging, diabetes, obesity and lack of exercise, cardio-
vascular disease and hypertension, smoking, chronic kidney disease, lower urinary 
tract symptoms, neurological disorders, depressive symptoms, drugs, sleep apnea 
syndrome, etc. As a treatment, oral preparations such as sildenafil and intraspinal 
injection are used. However, patients often change treatment methods due to lack 
of therapeutic effects and the high costs. Therefore, a therapeutic approach that 
emphasizes long-term satisfaction is needed.
The magnetic field induces an alternating current in the electrolyte in the body, 
which affects the water content of cells, mitochondrial function, nutrition, oxygen, 
amino acid uptake, energy production, etc. Appropriate magnetic fields can increase 
the uptake of oxygen by cells, promote blood circulation, and restore dysfunction. 
In a canine study, magnetic stimulation of the corpus cavernosum nerve increased 
intracavitary pressure, resulting in a complete penis erection after an incubation period 
of approximately 8 seconds. Upon discontinuation of stimulation, erection and intra-
cavitary pressure returned to baseline after an average of 14 seconds [27]. In a study of 
32 neuropathic ED patients and 20 healthy volunteers, a magnetic coil was placed on the 
dorsal side of the penis near the symphysis pubis, with 40% strength, 20 Hz frequency, 
and 50 seconds of magnetism. The stimulation was performed, and 50 seconds later, 
the magnetic stimulation was stopped. As a result, the magnetic therapy group was 
able to induce penile stiffness non-invasively without side effects [28]. A double-blind, 
placebo-controlled trial evaluating the effectiveness of impulse magnetic-field therapy 
for psychogenic erectile dysfunction or orgasmic disorders has also been reported [29]. 
Twenty men between the ages of 30 and 60 who suffered from ED and orgasm dysfunc-
tion were treated with Impulse magnetic-field therapy for 3 weeks, and the treatment 
group showed improved erection intensity, duration, well-being and sexual activity as 
compared to the placebo group [29]. No side effects from treatment were reported.
The data above supports the effectiveness of magnetic therapy for various types 
of ED, drawing more and more attention to magnetic therapy in the men’s health 
community.
7. Frail and sarcopenia
Frail is a state that shows vulnerability to external stress with aging, and is said 
to be different from the state requiring nursing care. There is no global definition of 
frailty or diagnostic criteria, but Fried’s criteria are widely adopted [30]. It has been 
pointed out that the onset of frailty is related to the decrease in hormone levels such 
as sex hormones and vitamin D, nutritional status and nutrient intake, and the rela-
tionship between low testosterone status and frailty syndrome, physical function, 
and fall risk [31]. In addition, a study analyzing the relationship between frailty and 
urinary incontinence in 300 elderly people in Italy found that elderly people with 
urinary incontinence were at significantly higher risk of being classified as frailty, 
and urinary incontinence is a marker of frailty in the elderly [32].
Sarcopenia’s pathology is similar to the frailty syndrome and is also a major con-
tributor to the physical frailty syndrome, defined as age-related loss of muscle mass 
and strength. Frail’s phenotype can be broadly divided into five types. That is, mal-
nutrition (weight loss), subjective decreased vitality (easy fatigue), decreased activ-
ity, decreased mobility (decreased walking speed), and decreased muscle strength 
(decreased grip strength). Of these, weakness and weakness are called physical 
frailty and are elements of sarcopenia. Sarcopenia has been attracting attention in 
recent years as a cause of bedridden and fall risk in the elderly. The prevalence of 
sarcopenia is estimated to be approximately 9% in young women and approximately 
18% in older men [33]. The causes of sarcopenia are qualitative changes accom-
panied by functional decline such as fast muscle fiber-specific atrophy, decreased 
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fiber count, and connective tissue hyperplasia due to changes in nutritional status, 
decreased physical activity, and production of inflammatory cytokines.
Eddy currents caused by magnetic stimulation induce contraction of skeletal 
muscle by causing depolarization of cell membranes of peripheral nerves and 
skeletal muscle. Electrical stimulation has been widely used in the clinical setting 
of conventional rehabilitation, but rehabilitation by painless magnetic stimulation 
is expected in the future. In addition, a study examining the relationship between 
sarcopenia and ADL in patients with early-stage Alzheimer’s suggests that disori-
entation and sarcopenia may interact to induce functional urinary incontinence. In 
addition, another study examining the correlation between dysuria and the overall 
functioning of the elderly found a significant correlation between urinary storage 
symptoms and the Barthel Index, suggesting that improvement in dysuria leads to 
improvement in symptoms, including sarcopenia. From these reports, magnetic 
therapy is expected to improve muscle mass and dysuria in sarcopenia patients, and 
may be a breakthrough non-invasive therapy in our aging society.
8. Current status of magnetic therapy in Japan and our efforts
In Japan, insurance is applied to female patients with intractable overactive blad-
der who do not improve their symptoms even after taking a urinary incontinence drug 
Figure 1. 
A device of magnetic stimulation therapy (Starformer by Fotona).
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for 12 weeks or more, or who cannot use the drug due to the side effects of the drug. 
Insurance can be calculated up to 2 courses per year, with 6 weeks as 1 course, up to 
25 minutes each time, up to 2 times a week. Considering reports from other countries, 
the usefulness of magnetic therapy is considered to span multiple diseases, and the 
therapeutic indication in Japan is still narrow. Therefore, our related facilities are 
providing treatment to patients with a wide range of diseases by introducing overseas 
magnetic stimulators (Figure 1). Although the number of cases is still small, magnetic 
therapy is performed for 20 to 30 minutes at a time, 1 to 2 times a week, for a total of 
8 times as one course. Comparing the questionnaires before and after the treatment, 
both men and women showed improvement in nocturia, urinary incontinence, and 
sexual dysfunction in men, and felt the effectiveness of magnetic treatment. In fact, 
patients said “the number of nighttime urinations did not improve with drug therapy 
or physical therapy but decreased from 3 to 1 since I started magnetic therapy”, “the 
intervals between urination has increased and it has become easier during the day 
and night”, “urine leakage has improved and pad replacement has decreased”, “erectile 
power has improved”, and “I have improved my back pain after magnetic therapy.” If 
the effect is poor in one cool, a second cool is recommended, and might improve the 
effects. I feel that it is necessary to increase the number of cases in future in order to 
expand the scope of application of magnetic therapy in Japan.
9. Conclusions
Magnetic therapy is a safe, non-invasive treatment that could be potentially 
used to treat pollakiuria, incontinence, men’s health, and sarcopenia. With further 
research evidence in the future, it may become the gold standard for the initial 
treatment of pelvic dysfunction.
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